Nexalin Technology (NXL) Total Current Liabilities (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Total Current Liabilities of $808364.0 for Q1 2026, up 40.65% year-over-year from $574736.0 in Q1 2025, and down 8.9% quarter-over-quarter from $887333.0 in Q4 2025.
Nexalin Technology (NXL) Total Current Liabilities (2021 - 2026) Analysis & Trends
Nexalin Technology's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $808364.0 for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 40.65% year-over-year to $808364.0; the TTM figure through Mar 2026 stood at $808364.0 (up 40.65% YoY), while the FY2025 annual figure was $887333.0, up 62.31% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $808364.0, down from $887333.0 in the prior quarter.
- The five-year high for Total Current Liabilities was $2.0 million in Q3 2022, with the low at $212104.0 in Q2 2024.
- The 5-year median for Total Current Liabilities is $600584.0 (2025), against an average of $848247.6.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities tumbled 82.06% in 2024, then jumped 183.16% in 2025.
- Nexalin Technology's Total Current Liabilities stood at $1.9 million in 2022, then plunged by 78.18% to $425281.0 in 2023, then grew by 28.55% to $546694.0 in 2024, then surged by 62.31% to $887333.0 in 2025, then dropped by 8.9% to $808364.0 in 2026.
- Business Quant data shows NXL's Total Current Liabilities at $808364.0 in Q1 2026, $887333.0 in Q4 2025, and $357524.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | 1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 808,364.00 |
| Dec 31, 2025 | 887,333.00 |
| Sep 30, 2025 | 357,524.00 |
| Jun 30, 2025 | 600,584.00 |
| Mar 31, 2025 | 574,736.00 |
| Dec 31, 2024 | 546,694.00 |
| Sep 30, 2024 | 299,389.00 |
| Jun 30, 2024 | 212,104.00 |
| Mar 31, 2024 | 507,223.00 |
| Dec 31, 2023 | 425,281.00 |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 1.98 Mn |
| Dec 31, 2021 | 2.36 Mn |